Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfenex Awards Althea cGMP Contract | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pfenex Awards Althea cGMP Contract

Will manufacture protein for malaria vaccine

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfenex, Inc. has awarded Althea Technologies a contract for the cGMP manufacture of circumsporozoite protein (CSP) from Plasmodium falciparum, a malaria vaccine. Althea Technologies will use its cGMP-ready Pfenex Expression Technology-based production process. Processes for several additional malaria antigens are currently being developed at Pfenex.

“We are pleased to award this contract to Althea Technologies,” said Bertrand C. Liang, chief executive officer of Pfenex. “Pfenex Expression Technology has made the high titer production of full-length, soluble, active CSP antigen a reality; recombinant expression of full-length, stable CSP has eluded researchers for years and with our protein expression platform we have overcome those challenges. With Althea we can rapidly implement the large-scale cGMP production of the CSP necessary for future human clinical studies to support NIAID’s malaria vaccine development efforts.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics